Clinical trial
PEG-Interferon a-2b + Ribavirin for Treatment of Chronic HRN 005 Hepatitis C…
NCT00215891 · Hepatitis Resource Network, Other · Completed
Key facts
| NCT number | NCT00215891 |
|---|---|
| Title | PEG-Interferon a-2b + Ribavirin for Treatment of Chronic HRN 005 Hepatitis C Infection in HIV-Infected Persons Not Previously Treated With Interferon |
| Official title | PEG-Interferon a-2b + Ribavirin for Treatment of Chronic Hepatitis C Infection in HIV-Infected Persons Not Previously Treated With Interferon |
| Lead sponsor | Hepatitis Resource Network, Other |
| Collaborators | Integrated Therapeutics Group Industry Subsidiary of Schering-Plough |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Hepatitis C Infection in HIV-Infected Persons, HIV Infections |
| Intervention type | Drug |
| Interventions | PEG-Interferon a-2b + Ribavirin |
| Enrollment | 300 |
| First posted | Sep 22, 2005 |
| Last update posted | Oct 25, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: